📋 About Your Medication
Bliv offers both compounded GLP-1 medications prepared by licensed compounding pharmacies, and access to branded GLP-1 medications manufactured by Novo Nordisk (Ozempic®, Wegovy®) and Eli Lilly (Mounjaro®, Zepbound®). Your prescription will specify which type you have been prescribed. Compounded medications are not FDA-approved finished drug products, though they are prepared under federal standards by licensed pharmacies. Branded medications are FDA-approved. If you have questions about which medication you are receiving, please check your prescription label or contact your Bliv provider.
Dose Escalation Is a Guide, Not a Requirement
Your dosing plan outlines a gradual escalation schedule, but that schedule is a clinical starting point — not a mandate. Many patients find an effective dose and stay there for the remainder of their treatment. You are not required to keep increasing simply because the schedule says to.
Signs Your Current Dose Is Working
You are making consistent, steady progress toward your goals
Your appetite is meaningfully reduced and you feel satisfied with smaller meals
Side effects have resolved or are minimal and manageable
You feel well overall and are not experiencing disruptions to daily life
When Escalating May Make Sense
A dose increase is worth discussing with your Bliv provider if:
Your progress has stalled for four or more consecutive weeks
You are not experiencing meaningful appetite suppression
You have been tolerating your current dose for several weeks without significant side effects
Any change to your prescribed dose requires provider approval. Do not adjust your dose independently.
The Goal Is the Lowest Effective Dose
The aim of GLP-1 therapy is not to reach the highest possible dose — it is to find the lowest dose that produces consistent results with the fewest side effects.
How to Discuss a Dose Change